Lab Member

Wanzun Lin

林万尊

Position：

Postdoctoral Fellow (2024)

Email：

Education:

2023   Fudan University                                   Ph.D.

2019    Fujian Medical University                            M.S.

2016    Chongqing Medical University                  B.S.

Research interest:

The roles of RNA modification in cancer immunology.

Publication:

1.     Lin, W., Chen, L., Zhang, H., Qiu, X., Huang, Q., Wan, F., Le, Z., Geng, S., Zhang, A., Qiu, S., Chen, L., Kong, L., Lu, J.J., 2023. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun 14, 265.

2.     Lin, W., Gao, J., Zhang, H., Chen, L., Qiu, X., Huang, Q., Hu, J., Kong, L., Lu, J.J., 2022. Identification of molecular subtypes based on inflammatory response in lower-grade glioma. Inflamm Regen 42, 29.

3.     Lin, W., Qiu, X., Sun, P., Ye, Y., Huang, Q., Kong, L., Lu, J.J., 2021. Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma. Mol Ther Oncolytics 21, 288-302.

4.     Lin, W., Sun, Y., Qiu, X., Huang, Q., Kong, L., Lu, J.J., 2021. VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy. J Neuroinflammation 18, 165.

5.     Lin, W., Xu, Y., Gao, J., Zhang, H., Sun, Y., Qiu, X., Huang, Q., Kong, L., Lu, J.J., 2021. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma. Front Immunol 12, 757047.

6.     Lin, W., Xu, Y., Chen, X., Liu, J., Weng, Y., Zhuang, Q., Lin, F., Huang, Z., Wu, S., Ding, J., Chen, L., Qiu, X., Zhang, L., Wu, J., Lin, D., Qiu, S., 2020. Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunity. Theranostics 10, 4871-4884.

7.     Lin, W., Liu, J., Chen, J., Li, J., Qiu, S., Ma, J., Lin, X., Zhang, L., Wu, J., 2019. Peptides of tetraspanin oncoprotein CD151 trigger active immunity against primary tumour and experimental lung metastasis. EBioMedicine 49, 133-144.